e-learning
resources
Barcelona 2013
Monday, 09.09.2013
New frontiers for EBUS-TBNA: the mediastinum and beyond
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Assessment of
SHOX2
methylation in EBUS-TBNA specimen improves accuracy in lung cancer staging
K. Darwiche, R. Karpf-Wissel, S. Welter, R. Tetzner, D. Theegarten, L. Freitag (Essen, Berlin, Germany)
Source:
Annual Congress 2013 –New frontiers for EBUS-TBNA: the mediastinum and beyond
Session:
New frontiers for EBUS-TBNA: the mediastinum and beyond
Session type:
Oral Presentation
Number:
1999
Disease area:
Thoracic oncology
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
K. Darwiche, R. Karpf-Wissel, S. Welter, R. Tetzner, D. Theegarten, L. Freitag (Essen, Berlin, Germany). Assessment of
SHOX2
methylation in EBUS-TBNA specimen improves accuracy in lung cancer staging. Eur Respir J 2013; 42: Suppl. 57, 1999
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
Panel discussion: ICU admission of lung cancer patients – Is COVID-19 a game-changer?
Surgical vs non-surgical treatment of early stage non-small cell lung cancer: here's the fight
Related content which might interest you:
Methylation of p16 in EBUS-TBNA samples as a predictor of advanced disease in lung cancer
Source: Annual Congress 2013 –Genetics and genomics of lung disease
Year: 2013
Comparing performance and cost of EBUS-TBNA versus other methods for diagnosis and staging of non-small cell lung cancer (NSCLC)
Source: International Congress 2014 – Improving diagnosis of thoracic tumours
Year: 2014
Patient and procedure determinants of EBUS-TBNA accuracy in mediastinal staging of lung cancer
Source: Annual Congress 2013 –Progress in bronchoscopy and pathology techniques for diagnosis of thoracic malignancies
Year: 2013
Determinants of negative predictive value during EBUS-TBNA in diagnosis/staging of lung cancer
Source: International Congress 2015 – Developments in lung cancer diagnosis
Year: 2015
Dividing EBUS-TBNA samples for simultaneous histopathological and molecular analyses in lung cancer patients
Source: International Congress 2015 – Endoscopic ultrasound: an essential tool for interventional pulmonology
Year: 2015
Added value of EUS-B to EBUS for lung cancer staging
Source: International Congress 2015 – Endoscopic ultrasound: an essential tool for interventional pulmonology
Year: 2015
Correlation of FDG-PET/CT and EBUS-TBNA for nodal staging in lung cancer
Source: Annual Congress 2013 –New methods for diagnostic workup of lung cancer
Year: 2013
Feasibility of OSNA in EBUS-TBNA of lung cancer patients
Source: International Congress 2014 – EBUS-TBNA: beyond the tracheobronchial wall
Year: 2014
Bronchoscopic semantics and diagnosis of lung cancer
Source: Annual Congress 2013 –Progress in bronchoscopy and pathology techniques for diagnosis of thoracic malignancies
Year: 2013
Cytology sample from EBUS-TBNA for multi-gene analysis in non-small-cell lung cancer (NSCLC)
Source: International Congress 2014 – Improving diagnosis of thoracic tumours
Year: 2014
Variation in lung cancer diagnosis in England
Source: Annual Congress 2013 –Quality management in thoracic oncology
Year: 2013
Applicability of TBNA to peripheral lung lesion when transbronchial biopsy fails
Source: International Congress 2016 – The best clinical approach to lung diseases
Year: 2016
EBUS-TBNA for nodal restaging and relapse in lung cancer
Source: International Congress 2014 – Diagnosis, imaging and surgery for thoracic tumours
Year: 2014
Role of the EBUS-EUS-FNA combined approach by using single ultrasound bronchoscope for tissue diagnosis in mediastinal lymphadenopathy
Source: International Congress 2014 – Improving diagnosis of thoracic tumours
Year: 2014
Methilation status in EBUS-NA samples of lung cancer
Source: International Congress 2014 – Improving diagnosis of thoracic tumours
Year: 2014
Ultrasound guided true cut biopsy of peripheral lymph nodes as a staging procedure in patients with non-small cell lung cancer (NSCLC)
Source: International Congress 2016 – EBUS and transthoracic ultrasound
Year: 2016
Evaluation of response to chemotherapy with fiberoptic bronchoscopy in lung cancers
Source: International Congress 2016 – Lung cancer: therapeutic modalities, re-staging, and follow-up
Year: 2016
A novel technique for CT-guided transthoracic biopsy of lung lesions with improved accuracy and safety
Source: International Congress 2015 – Transbronchial and percutaneous approach to peripheral pulmonary lesions
Year: 2015
Genetic mutations in transbronchial lung biopsy of peripheral lesions
Source: International Congress 2016 – Transbronchial diagnostics: from ILD to pheripheral lesions
Year: 2016
Accuracy of endobronchial ultrasound (EBUS) for evaluation of N2/3 disease in lung cancer: Experience over six years
Source: International Congress 2014 – New trends in bronchoscopy: EBUS-TBNA and endoscopic treatment of emphysema
Year: 2014
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept